Skip to content

Faculty profile

Shao-Ling Zhang

Back to faculty
ResearcherCentre de rechercheUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Latest papers

  • Dapagliflozin, in addition to ramipril, ameliorates kidney disease progression in mice with Alport syndrome.

    American journal of physiology. Renal physiology · 2025

  • Canagliflozin inhibits hedgehog interacting protein (Hhip) induction of tubulopathy in diabetic Akita mice.

    Translational research : the journal of laboratory and clinical medicine · 2025 · senior author

  • Heterogeneous nuclear ribonucleoprotein F deficiency in mouse podocyte promotes podocytopathy mediated by methyltransferase-like 14 nuclear translocation resulting in Sirtuin 1 gene inhibition.

    Translational research : the journal of laboratory and clinical medicine · 2024 · senior author

All 37 publications

Latest funding

  • Unlocking the Potential: The Activation of Angiotensin Type 2 Receptor (AT2R) Prevents Diabetic Kidney Disease in a Sex-Specific Manner

    CIHR · 2025 · Nominated PI

    $925,650
  • Renal Tubule-Specific Angiotensinogen Knockout Ameliorates Diabetic Kidney Disease in Type 1 Diabetic Akita Mice

    CIHR · 2023 · Supervisor

    $1,490
  • Canagliflozin Inhibits Hedgehog Interacting Protein (Hhip)-Mediated Renal Tubular Cell Senescence in Type 1 Akita Mice

    CIHR · 2023 · Supervisor

    $1,500
All 17 grants and awards
Something wrong or missing on this profile? Suggest a correction